CD14 and atherosclerosis: Intermediate (CD14+CD16+) and non-classical or inflammatory (CD14+CD16++) subsets produce large amounts of proinflammatory mediators and are up-regulated in many inflammatory disorders, such as rheumatoid arthritis, atherosclerosis, bacterial sepsis and various hepatic diseases.